Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin β3

Immunological Investigations

Volumn 31, Issue 1, 2002, Pages 51-69

  Lou, Yan Yan ^a   Wei, Yu Quan ^a   Yang, Li ^a   Zhao, Xia ^a,b   Tian, Ling ^a   Lu, You ^a   Wen, Yan Jun ^a   Liu, Fen ^a   Huang, Mei Juan ^a   Kang, Bin ^a   Xiao, Fei ^a   Su, Jing Mei ^a   He, Qu Ming ^a   Xie, Xing Jiang ^a   Mao, Yun Qiu ^a   Lei, Song ^a   Liu, Ji Yan ^a   Lou, Fen ^a   Zhou, Li Qun ^a   Peng, Feng ^a   Jiang, Yu ^a   Hu, Bing ^a   more..

^a SICHUAN UNIVERSITY   (China)

^b WEST CHINA UNIVERSITY OF MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA3 INTEGRIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; PLASMID DNA; TUMOR VACCINE;

ADOPTIVE TRANSFER; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOIMMUNITY; CANCER IMMUNOTHERAPY; CHICK EMBRYO; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; IMMUNOGENETICS; LIGAND BINDING; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE; TUMOR IMMUNITY; WESTERN BLOTTING;

ANIMALS; AUTOANTIBODIES; CANCER VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; COS CELLS; INTEGRIN BETA3; LIGANDS; MICE; NEOVASCULARIZATION, PATHOLOGIC; VACCINATION; VACCINES, DNA;

EID: 0036230027     PISSN: 08820139     EISSN: None     Source Type: Journal    
DOI: 10.1081/IMM-120003221     Document Type: Article

References (45)

1. What is the evidence that tumors are angiogenesis dependent?
2. Clinical application of angiogeneic growth factors and their inhibitors
3. Mechanism of angiogenesis
4. Angiogenesis and tumor metastasis
5. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis
6. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
7. A cancer therapy resistant to resistant
8. The implications of angiogenesis for the biology and therapy of cancer metastasis
9. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
10. The role of integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
11. 3 antagonist
12. 3 prevents maturation of blood vessels during embryonic neovascularization
13. 3
14. v antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastasis
15. 3-class integrins mediate fibronectin binding activity at the surface of developing mouse peri-implantation blastocysts
16. A series of function blocking antibodies against the alpha v beta 3 integrin bind allosteric to the ligand-binding site and induce ligand dissociation
17. 3 for angiogenesis
18. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
19. The drosophila genome sequence: Implications for biology and medicine
20. Immunogene therapy of tumors with vaccine based on xenopus homologous vascular endothelial growth factor as a model antigen
21. Induction of apotosis by quercetin: Involvement of heat shock protein
22. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
23. 5 integrin receptor antagonist
24. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
25. A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon α
26. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
27. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
28. Tumor antigens recognized by T cells
29. Cancer vaccines based on the identification of genes encoding cancer regression antigens
30. 3 blocks human breast cancer growth and angiogenesis in human skin
31. A novel disintegrin salmosin inhibits tumor angiogenesis
32. Integrins: Versatility, modulation, and signaling in cell adhesion
33. Platelet membrane glycoprotiens: Functions in cellular interactions
34. 3 (platlet GPIIb-IIIa)
35. 3 (glycoproteinIIb-IIIa) alter receptor affinity, specifinity, and function
36. Autoantibodies to alpha (IIb) beta (3) in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alpha (IIb)
37. Platelet-associated anti-glycoprotein (GP) IIb-IIIa auto-antibodies in chronic immune thyombocytopenic purpura mainly recognize cation-dependent conformations: Comparison with epitopes of serum autoantibodies
38. How the MHC selects Th1/Th2 immunity
39. T cell selection and autoimmunity: Flexibility and tuning
40. Inducing autoimmune disease to treat cancer
41. + T lymphocytes
42. The expanding universe of T-cell subsets: Th1, Th2 and more
43. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic Experimental Autoimmune Encephalomyelitis (EAE)
44. + T cells, are required for the development of experimental autoimmune gastritis
45. SS-56, a novel cellular target of autoantibody responses in sjogren syndrome and systemic lupus erythematosus